Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec;42(4):533-546.
doi: 10.1016/j.cll.2022.09.009.

Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing

Larisa H Cavallari  1 , Victoria M Pratt  2
Affiliations
Review

Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing

Larisa H Cavallari et al. Clin Lab Med. 2022 Dec.
No abstract available

Keywords: Evidence; Genotype; Outcomes; Pharmacogenomics; Reimbursement.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Patient-Specific Factors commonly influencing drug response
Figure 2.
Figure 2.
The process map for requesting a new CPT® from the American Medical Association (AMA) with how the US governmental payer determines a reimbursement value. The CCA = coding change application, CMS = Centers for Medicare and Medicaid Services, PFS = Physician fee schedule, CLFS = Clinical Lab fee schedule, RUC = Specialty Society Relative Value Scale Update Committee or Relative Value Update Committee (pronounced "ruck“)
See this image and copyright information in PMC

References

    1. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015;372:793–5. - PMC - PubMed
    1. O'Donnell PH, Wadhwa N, Danahey K, et al. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther 2017;102:859–69. - PMC - PubMed
    1. Hoffman JM, Haidar CE, Wilkinson MR, et al. PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet 2014;166C:45–55. - PMC - PubMed
    1. Peterson JF, Field JR, Unertl KM, et al. Physician response to implementation of genotype-tailored antiplatelet therapy. Clin Pharmacol Ther 2016;100:67–74. - PMC - PubMed
    1. Pulley JM, Denny JC, Peterson JF, et al. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharmacol Ther 2012;92:87–95. - PMC - PubMed

Publication types